2026 has seen profound shifts in global provision of healthcare and pharmaceutical markets: will 2027 be an even wilder ride?

This webinar gives leaders in healthcare and pharma a wide-ranging take on the bigger picture, with the frame of nine issues, policy and macro-economic, innovation and therapeutic, and business and competitive, which will shape strategy and tactics, globally and at country level for 2027 and beyond.

The webinar will use unique IQVIA data and analysis to provide new perspectives and novel insights on some of the biggest challenges and opportunities facing life sciences in the next year, from AI reshaping the commercial environment, Cardiovascular and Metabolic market futures, US and Chinese policies, and the rise of consumerisation in prescription medicines markets.

Key takeaways:

• Key events and issues to look out for shaping the global pharmaceutical market and healthcare in 2027 and beyond
• Insights into what this means for pharmaceutical companies as they plan the future of their global strategy, launch and commercial model